DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $12.00 by Analysts at Wells Fargo & Company

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective reduced by analysts at Wells Fargo & Company from $15.00 to $12.00 in a report released on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price target would suggest a potential upside of 7.33% from the company’s current price.

Other equities analysts have also issued reports about the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Barrington Research restated an “outperform” rating and issued a $18.00 price target on shares of DENTSPLY SIRONA in a research report on Wednesday, October 29th. Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Mizuho set a $13.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday. Finally, Stifel Nicolaus set a $13.00 target price on shares of DENTSPLY SIRONA in a report on Thursday. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $16.42.

DENTSPLY SIRONA Trading Up 1.5%

Shares of NASDAQ:XRAY traded up $0.16 during mid-day trading on Friday, reaching $11.18. 6,022,108 shares of the company’s stock were exchanged, compared to its average volume of 3,066,049. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA has a twelve month low of $10.69 and a twelve month high of $20.59. The firm has a market capitalization of $2.23 billion, a price-to-earnings ratio of -2.36, a PEG ratio of 0.81 and a beta of 1.00. The business’s fifty day moving average price is $13.04 and its 200-day moving average price is $14.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. During the same period in the prior year, the business earned $0.50 earnings per share. The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of large investors have recently modified their holdings of XRAY. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth $27,000. Parkside Financial Bank & Trust boosted its holdings in DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the last quarter. Brooklyn Investment Group purchased a new position in DENTSPLY SIRONA during the first quarter worth about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA in the 1st quarter worth about $26,000. Finally, Caitong International Asset Management Co. Ltd increased its stake in DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 2,241 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.